Safety, Tolerability and Immunogenicity of a Recombinant Adenovirus Type 5 Vectored COVID-19 Vaccine in Healthy Adults in China: Preliminary Report of a First-In Human Single-Center, Open-Label, Dose-Escalating Clinical Trial

2020 ◽  
Author(s):  
Feng-Cai Zhu ◽  
Yu-Hua Li ◽  
Xu-Hua Guan ◽  
Li-Hua Hou ◽  
Wen-Juan Wang ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Preliminary Report ◽  
Recombinant Adenovirus ◽  
Adenovirus Type ◽  
Healthy Adults ◽  
Single Center ◽  
Open Label ◽  
Label Dose ◽  
Adenovirus Type 5 ◽  
Dose Escalating

scholarly journals Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo.

2021 ◽  
Vol 42 ◽  
pp. 101225
Author(s):  
Nathan W Cummins ◽  
Jason Baker ◽  
Rana Chakraborty ◽  
Patrick G Dean ◽  
Enrique Garcia-Rivera ◽  
...  
Keyword(s):  
Hiv Positive ◽  
Single Center ◽  
Open Label ◽  
Hiv Reservoir ◽  
Label Dose ◽  
Hiv Positive Adults ◽  
Dose Escalating
Sign in / Sign up

Export Citation Format

Share Document